Core Viewpoint - Shanghai Fosun Pharmaceutical Group Co., Ltd. has approved the initial grant list for the 2025 A-share stock option incentive plan during the seventh meeting of its tenth board of directors [1] Group 1 - The company has outlined the names and positions of the proposed incentive recipients for the stock option plan [1] - The decision was made on August 22, 2025, indicating a strategic move to motivate and retain key personnel within the organization [1]

Core Viewpoint - The company announced the cancellation of a portion of stock options from its 2022 stock option incentive plan due to unmet performance conditions for the third exercise period, totaling 6.466547 million options [1][2][3]. Group 1: Stock Option Incentive Plan - The board of directors and the supervisory board approved the cancellation of stock options that were granted but not exercised due to the failure to meet performance conditions [1]. - The total number of stock options being canceled includes 6.33848 million options due to unmet performance criteria and 128,067 options from five individuals who no longer qualify as incentive targets [1][2]. - The cancellation process is in compliance with the relevant regulations and does not require further shareholder approval [1][3]. Group 2: Impact and Compliance - The cancellation of stock options will not have a substantial impact on the company's financial status or operational results [1][2]. - The remuneration and assessment committee, as well as the supervisory board, both agree that the cancellation aligns with regulatory requirements and does not harm the interests of the company or its shareholders [2][3]. - Legal opinions confirm that the necessary approvals and authorizations for the cancellation have been obtained, and the actions comply with the relevant regulations [3].

本计划可授予的A股期权上限为572.61万份，对应A股上限为572.61万股，分别约占公司股份总数的 0.2144%和公司A股总数(不包括A股库存股份)的0.2729%。本计划首次授予的激励对象不超过201人。首 次授予所涉A股期权的行权价格为27.93元/股。 复星医药（600196）(02196)公布，为进一步完善法人治理结构，建立、健全集团长期激励机制，吸引 和保留优秀人才，充分调动公司执行董事、职工董事、高级管理人员及集团员工的积极性，有效地将股 东利益、企业利益和集团核心团队个人利益结合在一起，使各方共同关注本集团的长远发展，并为之共 同努力奋斗，在充分保障股东利益的前提下，公司制定了2025年A股股票期权激励计划(草案)。 ...

智通财经APP讯，复星医药(02196)公布，为进一步完善法人治理结构，建立、健全集团长期激励机制， 吸引和保留优秀人才，充分调动公司执行董事、职工董事、高级管理人员及集团员工的积极性，有效地 将股东利益、企业利益和集团核心团队个人利益结合在一起，使各方共同关注本集团的长远发展，并为 之共同努力奋斗，在充分保障股东利益的前提下，公司制定了2025 年 A 股股票期权激励计划(草案)。 本计划可授予的 A 股期权上限为572.61万份，对应 A 股上限为572.61万股，分别约占公司股份总数的 0.2144%和公司 A 股总数(不包括 A 股库存股份)的 0.2729%。本计划首次授予的激励对象不超过 201 人。首次授予所涉 A 股期权的行权价格为 27.93 元/股。 ...

Core Viewpoint - The legal opinion letter from Beijing King & Wood Mallesons confirms that JA Solar Technology Co., Ltd. is qualified to implement its 2025 stock option incentive plan, which aims to enhance corporate governance and motivate key personnel for sustainable development [1][31]. Group 1: Company Background and Legal Framework - JA Solar Technology Co., Ltd. was formerly known as Qinhuangdao Tianye Tonglian Heavy Industry Co., Ltd. and changed its name after acquiring 100% of JA Solar Co., Ltd. in 2019 [4][5]. - The company is legally established and in good standing, with a registered capital of approximately 3.31 billion RMB [5]. - The legal opinion is based on the current laws and regulations in mainland China, excluding any laws from Hong Kong, Macau, or Taiwan [2]. Group 2: Incentive Plan Overview - The 2025 stock option incentive plan aims to improve the company's governance structure and establish a robust incentive and restraint mechanism [9][31]. - The plan includes provisions for the management structure, criteria for selecting incentive recipients, and the rights and obligations of both the company and the recipients [7][10]. Group 3: Eligibility and Scope of Incentive Recipients - The incentive recipients include 1,975 individuals, such as directors (excluding independent directors), senior management, and core technical personnel, who are directly influential to the company's performance [11][10]. - The plan excludes independent directors, supervisors, and shareholders holding more than 5% of the company's shares [11][10]. Group 4: Stock Options and Conditions - The stock options granted under the plan will be sourced from repurchased shares or newly issued shares to the incentive recipients [12]. - The total number of stock options granted will not exceed 10% of the company's total share capital, and no individual recipient will receive more than 1% of the total share capital [12][11]. Group 5: Pricing and Performance Conditions - The exercise price for the stock options is set at 9.15 RMB per share, which is below the average trading price prior to the announcement [20][21]. - The plan includes performance conditions based on the company's net profit for the years 2025 and 2026, with specific targets for each year [24][23]. Group 6: Legal Compliance and Procedures - The company has followed the necessary legal procedures for the implementation of the incentive plan, including board approvals and compliance with relevant laws [26][28]. - The plan will be subject to further disclosures and approvals as required by the regulatory framework [28][31].

晶澳太阳能科技股份有限公司 2025 年股票期权激励计划实施考核管理办法 晶澳太阳能科技股份有限公司 步完善公司法人治理结构，健全公司的激励约束机制，形成良好均衡的价值分配 体系，充分调动公司核心团队的积极性，有效地将股东利益、公司利益和核心团 队个人利益结合在一起，使各方共同关注公司的长远发展，确保公司发展战略和 经营目标的实现，公司拟实施 2025 年股票期权激励计划（以下简称"本激励计 划"）。 为保证本激励计划的顺利实施，现根据《中华人民共和国公司法》《中华人 民共和国证券法》《上市公司股权激励管理办法》等有关法律、法规和规范性文 件、以及公司章程的相关规定，并结合公司的实际情况，特制定本办法。 一、考核目的 进一步完善公司法人治理结构，建立和完善公司激励约束机制，保证本激励 计划的顺利实施，并在最大程度上发挥股权激励的作用，进而确保公司发展战略 和经营目标的实现。 二、考核原则 考核评价必须坚持公正、公开、公平的原则，严格按照本办法和考核对象的 业绩进行评价，以实现本激励计划与激励对象工作业绩、贡献紧密结合，从而提 高公司整体业绩，实现公司与全体股东利益最大化。 三、考核范围 本办法适用于参与公司本 ...

Group 1 - The company has announced a stock option incentive plan for 2025, detailing the allocation of stock options to key personnel [1] - A total of 1,975 individuals are included in the incentive plan, with the total stock options granted amounting to 16,177.6185 million shares, representing 4.89% of the company's total share capital [1] - Specific allocations include 492,000 options for the Vice General Manager, 583,000 for the Financial Officer, and 168,000 for a Board Member, among others [1] Group 2 - The incentive plan stipulates that no individual can receive more than 1% of the total share capital through the stock options granted [1] - The total number of stock options involved in the incentive plan does not exceed 10% of the company's total share capital at the time of the announcement [1] - The company has established a board of directors consisting of 11 members, with the term starting from the election by the employee representative assembly [1]

证券代码：002459 证券简称：晶澳科技 公告编号：2025-071 债券代码：127089 债券简称：晶澳转债 晶澳太阳能科技股份有限公司 第六届董事会第四十三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 晶澳太阳能科技股份有限公司（以下简称"公司"）第六届董事会第四十三 次会议于 2025 年 8 月 22 日在公司会议室以现场结合通讯表决方式召开。 召开本次会议的通知于 2025 年 8 月 12 日以电话、电子邮件等方式通知了各 位董事。本次会议由公司董事长靳保芳先生主持，会议应出席董事 9 名，实际出 席董事 9 名，符合《中华人民共和国公司法》及《公司章程》的规定。经与会董 事认真审议，会议以记名投票表决方式通过如下议案： 一、审议通过《关于<2025 年半年度报告>及<2025 年半年度报告摘要>的议 案》 表决结果：9 票同意，0 票反对，0 票弃权。 本议案已经董事会审计委员会审议通过。 具体内容详见同日披露于巨潮资讯网（http://www.cninfo.com.cn）的《2025 年半年度报告》及《2025 年半年度报 ...

证券代码：002459 证券简称：晶澳科技 公告编号：2025-072 债券代码：127089 债券简称：晶澳转债 晶澳太阳能科技股份有限公司 第六届监事会第二十四次会议决议公告 一、审议通过《关于<2025 年半年度报告>及<2025 年半年度报告摘要>的议 案》 经审核，监事会认为董事会编制和审议公司 2025 年半年度报告及其摘要的 程序符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完整地反 映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 表决结果：3 票同意，0 票反对，0 票弃权。 具体内容详见同日披露于巨潮资讯网（http://www.cninfo.com.cn）的《2025 年半年度报告》及《2025 年半年度报告摘要》。 二、审议通过《关于<2025 年半年度募集资金存放与使用情况的专项报告> 的议案》 经审核，监事会认为公司募集资金的管理、使用及运作程序符合《深圳证券 交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》和《公司募集 资金专项存储及使用管理制度》的规定，募集资金的实际使用合法、合规，未有 违反法律、法规及损害股东利益的行为。 表决结果： ...

Meeting Overview - The company will hold its fourth extraordinary general meeting of shareholders in 2025, convened by the sixth board of directors [1][2] - The meeting will take place on September 4, 2025, at 15:00, combining on-site and online voting methods [1][2] - Shareholders registered by the close of trading on September 3, 2025, are eligible to attend and vote [2] Agenda Items - The meeting will review several proposals, including amendments to the company's articles of association and independent director system related to the issuance of H shares [2][3] - Proposals for the 2025 stock option incentive plan and employee stock ownership plan will also be discussed [2][3] - Certain proposals require a special resolution, needing approval from over two-thirds of the voting rights held by attending shareholders [3] Voting Procedures - Shareholders can register for the meeting through various methods, including on-site registration and mail [4] - Voting will be conducted through the Shenzhen Stock Exchange trading system and internet voting system, with specific procedures outlined for participation [5][6] - The voting period will start at 9:15 AM on September 4, 2025, and end at 3:00 PM on the same day [6] Contact Information - The company provides contact details for inquiries related to the meeting, including phone, fax, and email [5]